Every week, MedCity News highlights the best of its MedCitizens: syndication partners and MedCity News readers who contribute to MedCityNews.com. The MedCitizens are sponsored by MyPRGenie, the only Do-It-Yourself, PR platform and news wire that gives you access to more than 540,000 journalist contacts.
Now here’s the best of what YOU had to say:
- Biotronik outlines ‘exploding’ defibrillator response. “Friday evening, I met with Rex Richmond and Dan Schlewitz from Biotronik Inc. to hear their side of the controversy surrounding the withdrawal of a case report previously published in Europace pertaining to an “exploding” Biotronik implantable cardiac defibrillator.”
- Former Boston Scientific leader raises $33M for new device company. “NinePoint Medical Inc. raised a $33 million Series A round to develop an in vivo pathology device the company hopes will eventually allow doctors to diagnose and treat cancerous cells during biopsy procedures…. NinePoint is led by president and CEO Dr. Charles Carignan, formerly Boston Scientific Corp.’s (NYSE:BSX) chief medical officer.”
- Electronic medical records’ truths and myths. “I do believe that EMR systems in time will fulfill their early promises…. But, some of today’s EMR whistles are whistling in the dark.”
- Health IT headed toward genomic medicine. “A major goal for genomics scientists is the integration of the gene into healthcare information technology… [but] healthcare IT is already heading in the direction of biomarker-based medicine.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
